These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7975254)

  • 21. A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa.
    Zhao B; Marshall DR; Sample CE
    J Virol; 1996 Jul; 70(7):4228-36. PubMed ID: 8676443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes.
    Johannsen E; Miller CL; Grossman SR; Kieff E
    J Virol; 1996 Jun; 70(6):4179-83. PubMed ID: 8648764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on transforming functions of Epstein-Barr virus-specific proteins].
    Kinoshita T
    Hokkaido Igaku Zasshi; 1990 Jul; 65(4):362-75. PubMed ID: 2172130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of LMP and EBNA genes in Epstein-Barr virus-associated lymphomas in Hu-PBL/SCID mice.
    Tang Y; Lu S; Gan X; Liu F; Zhang Y; Luo C; Pan Y; Hong L; Gan R
    Oncol Rep; 2016 Feb; 35(2):905-11. PubMed ID: 26548532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    Cohen JI; Wang F; Kieff E
    J Virol; 1991 May; 65(5):2545-54. PubMed ID: 1850028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elements.
    McClellan MJ; Khasnis S; Wood CD; Palermo RD; Schlick SN; Kanhere AS; Jenner RG; West MJ
    J Virol; 2012 May; 86(9):5165-78. PubMed ID: 22357270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological detection of proteins associated with the Epstein-Barr virus nuclear antigen 2A.
    Grässer FA; Sauder C; Haiss P; Hille A; König S; Göttel S; Kremmer E; Leinenbach HP; Zeppezauer M; Mueller-Lantzsch N
    Virology; 1993 Aug; 195(2):550-60. PubMed ID: 8337830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure and function of the Epstein-Barr virus transcription factor, EBNA 3C.
    West MJ
    Curr Protein Pept Sci; 2006 Apr; 7(2):123-36. PubMed ID: 16611138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
    Murray RJ; Kurilla MG; Brooks JM; Thomas WA; Rowe M; Kieff E; Rickinson AB
    J Exp Med; 1992 Jul; 176(1):157-68. PubMed ID: 1319456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.
    Tursiella ML; Bowman ER; Wanzeck KC; Throm RE; Liao J; Zhu J; Sample CE
    PLoS Pathog; 2014 Oct; 10(10):e1004415. PubMed ID: 25275486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus latent genes.
    Kang MS; Kieff E
    Exp Mol Med; 2015 Jan; 47(1):e131. PubMed ID: 25613728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro.
    Cohen JI; Picchio GR; Mosier DE
    J Virol; 1992 Dec; 66(12):7555-9. PubMed ID: 1331538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus gene expression in nasopharyngeal carcinoma.
    Young LS; Dawson CW; Clark D; Rupani H; Busson P; Tursz T; Johnson A; Rickinson AB
    J Gen Virol; 1988 May; 69 ( Pt 5)():1051-65. PubMed ID: 2836550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
    Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-barr virus nuclear antigen-1 binds to nuclear transporter karyopherin alpha1/NPI-1 in addition to karyopherin alpha2/Rch1.
    Ito S; Ikeda M; Kato N; Matsumoto A; Ishikawa Y; Kumakubo S; Yanagi K
    Virology; 2000 Jan; 266(1):110-9. PubMed ID: 10612665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids.
    Contreras-Brodin BA; Anvret M; Imreh S; Altiok E; Klein G; Masucci MG
    J Gen Virol; 1991 Dec; 72 ( Pt 12)():3025-33. PubMed ID: 1662694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells.
    Roth G; Curiel T; Lacy J
    Blood; 1994 Jul; 84(2):582-7. PubMed ID: 8025284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus recombinants from overlapping cosmid fragments.
    Tomkinson B; Robertson E; Yalamanchili R; Longnecker R; Kieff E
    J Virol; 1993 Dec; 67(12):7298-306. PubMed ID: 8230453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.